Join The Team

Join The Team

When you work with BioPhorum, you can be sure that your team has the relevant, meaningful experience to help you and your business challenges.

All members of the BioPhorum team have a degree, with 60% holding a Master’s degree or higher, including 16% with an MBA and 24% a PhD.

Almost all client facing staff have more than 20 years of experience in a pharma or high tech manufacturing environment and many have more than ten years of consulting experience. Most team members have a form of black or green belt qualification as well as extensive experience leading improvement teams in highly complex production and research environments.

This blend of academic and practical experience combines to form a team of outstanding quality.

Without exception, our people work in BPOG because they gain a great personal satisfaction from interacting with the best people, helping them to improve performance in an industry that is pushing back the boundaries of human health and well-being like no other.

If you would like to learn more, contact us at info@biophorum.com.

Our highly experienced facilitators and account managers support the BioPhorum collaboration by creating a great environment where the industry’s subject matter experts come together and share approaches, solve mutual challenges and develop the guidance the industry needs to move its operations forward. Our people are typically ‘best in class’ Pharma/BioPharma operations, manufacturing professionals or process consultants, who have all gained an in-depth understanding of how industries evolve and become truly successful.

Our team is passionate about challenging and facilitating change within the biotech industry for the improvement and benefit of all.

 

What it is like to be a facilitator for BioPhorum

In 2009 my friend introduced me to a person, future mentor, who three years later hired me to start working at a large biopharmaceutical company as a part of his Operational Excellence team. My academic background was in Environmental Policy and Social Behavior and my career background had been within sales and marketing.

Although I knew little about the biopharmaceutical industry, Operational Excellence and Continuous Improvement (CI) at the time of being hired for this job my academic and career background up to that point had prepared me in many ways for my future career and I am grateful that my new boss was able to see that. You see CI is about change, about understanding the current state, defining the preferred future state, and help people transition into their future state. This is a cyclical process and is referred to by many names PDCA, DMAIC, SPRINT, etc. Environmental policy is about changing people. Sales and marketing is about understanding and delivering to the needs and preferences of the customer. All change and especially CI process management requires understanding the needs of the customer and creating a future preferred state that delivers to those needs. That brings me to my main take away from facilitating collaborations and problem solving in the biopharmaceutical industry.

Seek to understand, not to be understood.

When I joined the biopharmaceutical industry I was not a biopharmaceutical expert. Neither am I a nuclear physicist or political expert, but I bet I could still facilitate problem solving in those areas of work. Here is why: my role as a CI facilitator is to seek to understand, rather then to be understood. I found that when you genuinely seek to understand a situation, a problem, or a person’s point of view you automatically inspire others to ask questions. If you have the right people in the room then suddenly a tremendous sharing of knowledge happens.

So it is with any change. As a facilitator you do not need to be a subject matter expert on the topic at hand, but you need to ask questions and create an open environment where the experts participating in changing the status quo feel comfortable sharing their experience and seeking new knowledge that down the road contribute to a well thought out solution…or should I say preferred future state.

Biomanufacturers and suppliers seeking to change forecasting and supply planning

During the last 18 months I have worked as the facilitator in a group of forecasting and supply planning Subject Matter Experts (SMEs) that were tasked with defining best practice of forecasting and supply planning in the biopharmaceutical industry (not a small task).

The people in this team were complete strangers to each other and some of them competitors in the same industry. Normally during such circumstances people are hesitant to share their point of view. It can be for competitive reasons or, like in many situations, out of personal fear of not seeming knowledgeable enough. This group experienced that as well, but the advantage they have is that they are collaborating within the context of BioPhorum.

BioPhorum’s mission is to create an environment where the global biopharmaceutical industry can collaborate and accelerate their rate of progress for the benefit of all.The idea is that biopharmaceutical companies and suppliers with the same problems replace working on problems in isolation, with working on problems in collaboration so that the industry shares, learns and builds the best solutions together. As a facilitator in BioPhorum it is my job to create a safe environment for collaborating and sharing and to help this team deliver their objective, which again is to define what world class forecasting and raw material supply & demand planning looks like in an effort to drive improvement and implementation within the biopharmaceutical industry.

To help create the right environment we started out by aligning on what the SMEs had in common. Each of the participating SMEs was asked to share equitably by answering a very simple question: “what is and what is not working for you at the moment?”

For me as a facilitator this was about understanding the topic at hand and the current state. I was upfront and honest when I did not understand a term or thought process, which prompted others in the team to do the same. This helped resolve assumptions and alignment on language. We took the team’s collective answers, discussed them, and came up with a joint understanding of the current state.

In short the team felt that the industry supply chain was becoming more complex and constraints in the frame of quality, service level, and cost efficiency were becoming more stringent. Meanwhile, they agreed that forecasting and supply planning processes are relatively immature. However, by analyzing the current state of the leading biomanufacturing companies and suppliers they were able to achieve their goal of developing forecasting and raw material supply & demand planning best practice guidelines for the industry. You can learn in detail how they did this and what their conclusions were in their publications on the BioPhorum website.

So what it’s like to be a continuous improvement facilitator for BioPhorum?

I have the privilege to work with extremely talented SMEs in an environment that is conducive to collaboration, which is very helpful. However, no matter the circumstances my main takeaway for those reading this post is that collaboration is a journey that is best accomplished when you seek to understand rather then to be understood.

The BioPhorum facilitator’s role is to support benchmarking and best practice development between leading global biopharmaceutical companies. Ensuring the workstream outcomes are delivered and specific needs of member companies are met.

Experienced facilitators have the possibility to progress to a client relationship management role where they will work one to one with client leaders to help them manage the engagement of their operations with the BioPhorum groups. Ensuring members benefit from their collaboration and learning.

Why join our team?

– BioPhorum offers a unique opportunity to work in an industry-leading, high impact role facilitating collaborations between global leaders in the BioPharma/Biotech industries.

Flexibility – Being based from home, the role offers the opportunity to rebalance professional and personal life while still having the challenge of operating in an intellectually stimulating and dynamic environment.

Growth and opportunity – BioPhorum continues to grow its membership and, with new workstreams and programs going live, we are always interested in talking to experienced professionals who are passionate about collaboration and capable of supporting and driving change on a global scale.

For more information contact Cath Heath at:

Email: heathc@biophorum.com

Mobile: +44 (0)7792 706865

<!--

Jannika Kremer, Facilitator, Supply Partner Phorum      

Contact address

BioPhorum
The Gridiron Building
One Pancras Square
London
N1C 4AG

Newsletter subscribe

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.



© 2019 Biophorum Operations Group · All Rights Reserved

Registered Address: 5 Westbrook Court · 2 Sharrow Vale Road · Sheffield · S11 8YZ

Company Number 06794795 · VAT Number GB298617544

Driving progress in Cell & Gene Therapy

Now with 19 member companies and 183 subject matter experts, the BioPhorum Cell & Gene Therapy (C>) Phorum has made great strides since its formation[...]

Read More
Cell and Gene Therapy Phorum accelerates progress

The BioPhorum Cell & Gene Therapy Phorum has made significant progress since its creation in 2018 – from building networks and sharing knowledge to endorsing[...]

Read More
2018 highlights

BioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]

Read More
Industry bioassay approach helps to shape the future

In 2018, members of the Development Group Bioassay workstream came together to write a best practices paper on bioassay development. We are delighted to announce[...]

Read More
Sharing ideas on forced degradation

“Forced degradation studies are an important part of the drug lifecycle process as they can inform many aspects of drug development,” said Jennifer Halley, Principal[...]

Read More
The BioPhorum and USP collaborative journey to new standards

BioPhorum and United States Pharmacopeia (USP) share a common direction – to accelerate biopharma innovation, quality and progress through collaboration.

Read More
Proactive prioritization: a new tool for assessing raw material risk

The Raw Material Risk Management workstream has launched a new, raw material risk assessment tool aimed at helping industry identify and prioritize around the challenging[...]

Read More
How well can you handle SUS changes?  Take our surveys and see

BioPhorum delivery of value from the disposables five-year plan - supplier change notifications for single-use systems

Read More
Decision tree to support alignment of risk assessment for changes to single-use biomanufacturing systems

The BioPhorum single use change notification team has been working on developing and standardizing best practice for single use change notification since 2015.  The challenges[...]

Read More
PUPSIT – An update on BioPhorum/PDA work to develop a risk-based position
Read More
Driving the evolution of secondary packaging

How do we transition from large-batch manufacture to small-batch, high-value packaging runs?

Read More
Hi-tech ambitions for Fill Finish

The Fill Finish Phorum has recently embarked on a series of exciting and ambitious initiatives, exploring new technologies and processes to enhance the efficiency and[...]

Read More
Logistics collaboration hub: An opportunity for significant time and cost savings

Most biopharmaceutical manufacturers use a network of logistics service providers (LSPs) to deliver warehousing, transport and distribution services, and they are usually linked using customized,[...]

Read More
The ‘how to’ guide to implementing Agile in GxP

The publication of the Guidance on the use of Agile in a GxP Environment document in 2017 was well received.It described how the use of[...]

Read More
How smart is your maintenance?

Faster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]

Read More
BioPhorum’s Maturity Assessment Tool gains momentum
Read More
Supply chain, forecasting and demand planning solutions gain momentum

The relationship between suppliers and manufacturers is one of the most crucial in biopharmaceutical manufacturing. This is especially the case when forecasting and supply planning.[...]

Read More
2018 highlights

BioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]

Read More
Removing the roadblocks to continuous biomanufacturing

Continuous downstream processing is increasingly seen as a feasible approach for manufacturing biologics. The industry recognises that it offers advantages over batch-based processing by:

Read More
Changing mindsets with a modular approach

Historically, manufacturers have used a ‘waterfall’ approach when designing and building their production facilities, sequentially resolving and specifying all aspects up front and in detail[...]

Read More
How do you bring technology roadmapping to life?

You use it to make change happen and that is exactly what the Phorum’s leaders did after the first edition of the Biomanufacturing Technology Roadmaps[...]

Read More
Slicing years off change implementation

As the first regulatory authority in Latin America to gain full membership of the International Council for Harmonization (ICH), the Brazilian Health Regulatory Agency (Anvisa)[...]

Read More
BioPhorum Regulatory Interaction: helping to open doors

To implement any change in the biopharmaceutical manufacturing industry it is important to engage with and collaborate with the regulators. Set up two years ago,[...]

Read More
Regulatory compliance: what lessons can be learned?

BioPhorum delivery of value from the disposables five-year plan - supplier change notifications for single-use systems

Read More
Navigating the maze of medical technology regulation: a solo voyage or a team effort?

Medical technology is a global business, generating annual revenues of over $400bn. The sector encompasses a broad range of technologies: from in-vitro diagnostics and diagnostic[...]

Read More

IaaS Cloud webinar recording play back
Read More
New BPIT guidance to align cloud services to regulatory requirements
Read More
Data Integrity and Agile Webinars to support industry response to regulators
Read More
How to validate informatics in CPV programs

The BioPhorum Continued Process Verification (CPV) and Informatics team has published a paper to support a risk-based approach for the validation of informatics systems for[...]

Read More
Continued Process Verification delivering real saving in time and money

More than 50 per cent of biopharma products on the market now have Continued Process Verification (CPV) plans in place.  Thanks to the CPV white[...]

Read More
A roadmap for the implementation of continued process verification

This article provides a roadmap draws on the content of the CPV case study to provide a step-by-step guide in a more accessible form.

Read More
How smart is your maintenance?

Faster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]

Read More
Digital plant maturity model webinar replay
Read More
Digital Plant Maturity Model workstream to host webinar
Read More
New guidance available on Forecasting and Demand Planning to streamline supply chain performance
Read More
Host cell proteins poster

This poster presented at the BEBPA Conference, San Francisco builds and consolidates the information currently available in the industry for assessing process risk from Host[...]

Read More
Host cell protein risk assessment, an industry approach

Host cell protein (HCP) constitutes a significant class of process-related impurities in biological drugs.

Read More
BEBPA risk assessment workshop
Read More
PUPSIT – An update on BioPhorum/PDA work to develop a risk-based position
Read More
BioPhorum’s Maturity Assessment Tool gains momentum
Read More
Driving the evolution of secondary packaging

How do we transition from large-batch manufacture to small-batch, high-value packaging runs?

Read More